Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma

Ruizhi Zhang(Nanjing Medical University), Qing Li(Jiangsu Cancer Hospital)
iScience
April 26, 2024
Cited by 6


Related Papers